Englewood Lab, Inc.

KOSDAQ:A950140 Voorraadrapport

Marktkapitalisatie: ₩214.4b

Englewood Lab Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Englewood Lab heeft een totaal eigen vermogen van ₩130.5B en een totale schuld van ₩12.7B, wat de schuld-eigenvermogensverhouding op 9.7% brengt. De totale activa en totale passiva bedragen respectievelijk ₩177.8B en ₩47.3B. De EBIT Englewood Lab is ₩28.0B waardoor de rentedekking 160.4 is. Het heeft contanten en kortetermijnbeleggingen van ₩17.3B.

Belangrijke informatie

9.7%

Verhouding schuld/eigen vermogen

₩12.70b

Schuld

Rente dekkingsratio160.4x
Contant₩17.26b
Aandelen₩130.47b
Totaal verplichtingen₩47.29b
Totaal activa₩177.76b

Recente financiële gezondheidsupdates

Recent updates

Englewood Lab, Inc. (KOSDAQ:950140) Stocks Pounded By 28% But Not Lagging Market On Growth Or Pricing

Aug 07
Englewood Lab, Inc. (KOSDAQ:950140) Stocks Pounded By 28% But Not Lagging Market On Growth Or Pricing

We Think Englewood Lab (KOSDAQ:950140) Can Manage Its Debt With Ease

Jun 20
We Think Englewood Lab (KOSDAQ:950140) Can Manage Its Debt With Ease

Is Now The Time To Put Englewood Lab (KOSDAQ:950140) On Your Watchlist?

May 24
Is Now The Time To Put Englewood Lab (KOSDAQ:950140) On Your Watchlist?

A Piece Of The Puzzle Missing From Englewood Lab, Inc.'s (KOSDAQ:950140) 25% Share Price Climb

May 09
A Piece Of The Puzzle Missing From Englewood Lab, Inc.'s (KOSDAQ:950140) 25% Share Price Climb

Investors Shouldn't Overlook Englewood Lab's (KOSDAQ:950140) Impressive Returns On Capital

May 08
Investors Shouldn't Overlook Englewood Lab's (KOSDAQ:950140) Impressive Returns On Capital

When Should You Buy Englewood Lab, Inc. (KOSDAQ:950140)?

Apr 16
When Should You Buy Englewood Lab, Inc. (KOSDAQ:950140)?

There Are Reasons To Feel Uneasy About Englewood Lab's (KOSDAQ:950140) Returns On Capital

Mar 31
There Are Reasons To Feel Uneasy About Englewood Lab's (KOSDAQ:950140) Returns On Capital

If You Had Bought Englewood Lab (KOSDAQ:950140) Shares A Year Ago You'd Have Earned 106% Returns

Mar 17
If You Had Bought Englewood Lab (KOSDAQ:950140) Shares A Year Ago You'd Have Earned 106% Returns

What Kind Of Shareholders Hold The Majority In Englewood Lab, Inc.'s (KOSDAQ:950140) Shares?

Feb 23
What Kind Of Shareholders Hold The Majority In Englewood Lab, Inc.'s (KOSDAQ:950140) Shares?

These 4 Measures Indicate That Englewood Lab (KOSDAQ:950140) Is Using Debt Reasonably Well

Feb 05
These 4 Measures Indicate That Englewood Lab (KOSDAQ:950140) Is Using Debt Reasonably Well

Englewood Lab, Inc. (KOSDAQ:950140) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?

Jan 20
Englewood Lab, Inc. (KOSDAQ:950140) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?

Is Englewood Lab, Inc. (KOSDAQ:950140) Potentially Undervalued?

Jan 02
Is Englewood Lab, Inc. (KOSDAQ:950140) Potentially Undervalued?

Returns On Capital At Englewood Lab (KOSDAQ:950140) Paint An Interesting Picture

Dec 15
Returns On Capital At Englewood Lab (KOSDAQ:950140) Paint An Interesting Picture

Are Englewood Lab's (KOSDAQ:950140) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Nov 26
Are Englewood Lab's (KOSDAQ:950140) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( ₩131.0B ) A950140 } overtreffen de korte termijn passiva ( ₩40.2B ).

Langlopende schulden: De kortetermijnactiva A950140 ( ₩131.0B ) overtreffen de langetermijnschulden ( ₩7.1B ).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: A950140 heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van A950140 is de afgelopen 5 jaar gedaald van 43% naar 9.7%.

Schuldendekking: De schuld van A950140 wordt goed gedekt door de operationele kasstroom ( 60.2% ).

Rentedekking: De rentebetalingen op de schuld van A950140 worden goed gedekt door EBIT ( 160.4 x dekking).


Balans


Ontdek gezonde bedrijven